Vanguard Personalized Indexing Management LLC Reduces Holdings in Colgate-Palmolive Company $CL

Vanguard Personalized Indexing Management LLC reduced its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 23.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,151 shares of the company’s stock after selling 27,514 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Colgate-Palmolive were worth $7,291,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of CL. Asset Management One Co. Ltd. lifted its holdings in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after purchasing an additional 16,017 shares during the last quarter. Cidel Asset Management Inc. lifted its holdings in Colgate-Palmolive by 13.6% in the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after purchasing an additional 39,413 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Colgate-Palmolive by 1.2% in the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after acquiring an additional 993,432 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Colgate-Palmolive by 18.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock worth $2,752,000 after buying an additional 4,738 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in Colgate-Palmolive by 15.0% during the third quarter. Exchange Traded Concepts LLC now owns 400,137 shares of the company’s stock valued at $31,987,000 after buying an additional 52,261 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CL shares. Bank of America decreased their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Barclays set a $83.00 price target on Colgate-Palmolive in a research note on Friday, January 16th. Evercore ISI decreased their price objective on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Finally, UBS Group upped their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Eleven analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.44.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $85.86 on Wednesday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The business’s fifty day moving average is $80.32 and its two-hundred day moving average is $81.37. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. The firm has a market cap of $69.21 billion, a P/E ratio of 24.05, a P/E/G ratio of 5.75 and a beta of 0.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.91 EPS. Equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.